Vista Current Coverage

All Atossa Genetics, Inc. Articles

“Superfirms’ Domination Influences Economic Factors”

Vista Partners (“Vista”) has published September’s FREE Macroeconomic & Investment Monthly Newsletter, “Superfirms’ Domination Influences Economic Factors.” Vista’s monthly newsletter contains investment considerations for Banks, Biotech, Cloud Services, Energy, Fintech, Healthcare, Manufacturing, Mining, Materials, Nuclear Energy, Real Estate, and Technology. Vista Partners centers its Coverage...

San Diego-based Fate Therapeutics Enters Strategic Collaboration with Tokyo’s ONO Pharmaceutical Co.

San Diego-based Fate Therapeutics (Nasdaq: FATE) is a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorders. The Company is pioneering the development of off-the-shelf cell therapies using its proprietary induced pluripotent stem cell (iPSC) product platform. The Company’s immuno-oncology...

Have You Read “Vista Partners Weekly Market Update 9-15-18?”

Vista Partners published “Vista Partners Weekly Market Update 9-15-18!”  Each weekly issue is written by Vista Partners’ Managing Director, John Heerdink! Each weekly issue includes updates on the stock market, a “Stocks To Watch” section, & featured daily stories & videos from Vista’s Coverage Universe of...

“Predictably South” Vista Partners Weekly Market Update 9-8-18

Vista Partners has published “Predictably South” Vista Partners Weekly Market Update 9-8-18and is accessible on our Newsletters Page. Each issue is written by the Managing Director, John Heerdink and speaks to the activities of the market, influencers and specific featured stories from Vista’s Coverage Universe...